StonvexLoading…
StonvexCore line items from PFG's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $15.63B | $16.13B | $13.67B | $17.54B |
Operating Income | Not available | Not available | Not available | Not available |
Net Income | $1.19B | $1.57B | $623.20M | $4.76B |
EPS (Diluted) | $5.25 | $6.68 | $2.55 | $18.63 |
Total Assets | $341.38B | $313.66B | $305.05B | $290.87B |
Total Liabilities | $328.99B | $302.19B | $293.84B | $280.59B |
Cash & Equivalents | $4.43B | $4.21B | $4.71B | $4.85B |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 217.38M | 226.23M | 236.44M | 243.55M |